Gleason Group’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.4K Hold
2,712
﹤0.01% 221
2026
Q1
$10.7K Hold
2,712
﹤0.01% 174
2025
Q4
$18.4K Hold
2,712
﹤0.01% 158
2025
Q3
$18.9K Hold
2,712
﹤0.01% 146
2025
Q2
$16.6K Hold
2,712
﹤0.01% 153
2025
Q1
$20.6K Hold
2,712
﹤0.01% 143
2024
Q4
$26.1K Hold
2,712
﹤0.01% 137
2024
Q3
$16K Hold
2,712
﹤0.01% 150
2024
Q2
$18.8K Hold
2,712
﹤0.01% 166
2024
Q1
$20.9K Hold
2,712
﹤0.01% 145
2023
Q4
$23.8K Hold
2,712
0.01% 144
2023
Q3
$19.8K Hold
2,712
0.01% 153
2023
Q2
$17.9K Hold
2,712
﹤0.01% 158
2023
Q1
$9.25K Hold
2,712
﹤0.01% 179
2022
Q4
$7.54K Hold
2,712
﹤0.01% 180
2022
Q3
$8K Hold
2,712
﹤0.01% 186
2022
Q2
$9K Hold
2,712
﹤0.01% 173
2022
Q1
$13K Hold
2,712
﹤0.01% 165
2021
Q4
$16K Hold
2,712
0.01% 150
2021
Q3
$16K Hold
2,712
0.01% 150
2021
Q2
$34K Hold
2,712
0.01% 123
2021
Q1
$28K Hold
2,712
0.01% 121
2020
Q4
$25K Hold
2,712
0.01% 121
2020
Q3
$17K Hold
2,712
0.01% 124
2020
Q2
$15K Hold
2,712
0.01% 128
2020
Q1
$9K Hold
2,712
0.01% 139
2019
Q4
$21K Buy
+2,712
New +$21K 0.01% 133

Other funds holding MDXG

Gleason Group's MDXG Position: Q2 2026 in Review

Gleason Group held its MiMedx Group (MDXG) position steady in Q2 2026 at 2,712 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #221.

Gleason Group first reported a position in MDXG in Q4 2019 and has held it in 27 quarters since. The position peaked at $34K in Q2 2021. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Gleason Group held 2,712 shares of MiMedx Group worth $10.4K as of Q2 2026.
  • Gleason Group left its MiMedx Group share count unchanged in Q2 2026.
  • MiMedx Group made up ﹤0.01% of Gleason Group's portfolio in Q2 2026, its #221 holding.
  • Gleason Group first reported a position in MiMedx Group in Q4 2019 and has held it in 27 quarters since.
  • Gleason Group's MiMedx Group position peaked at $34K in Q2 2021.
  • 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Gleason Group's 13F filing for Q2 2026, filed 13 Jul 2026.